177 related articles for article (PubMed ID: 36293387)
1. SOX2 Promotes Invasion in Human Bladder Cancers through MMP2 Upregulation and FOXO1 Downregulation.
Xie Q; Hua X; Huang C; Liao X; Tian Z; Xu J; Zhao Y; Jiang G; Huang H; Huang C
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293387
[TBL] [Abstract][Full Text] [Related]
2. The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein.
Hua X; Huang M; Deng X; Xu J; Luo Y; Xie Q; Xu J; Tian Z; Li J; Zhu J; Huang C; Zhao QS; Huang H; Huang C
Cell Death Differ; 2020 Feb; 27(2):632-645. PubMed ID: 31243344
[TBL] [Abstract][Full Text] [Related]
3. RhoGDIβ promotes Sp1/MMP-2 expression and bladder cancer invasion through perturbing miR-200c-targeted JNK2 protein translation.
Huang H; Jin H; Zhao H; Wang J; Li X; Yan H; Wang S; Guo X; Xue L; Li J; Peng M; Wang A; Zhu J; Wu XR; Chen C; Huang C
Mol Oncol; 2017 Nov; 11(11):1579-1594. PubMed ID: 28846829
[TBL] [Abstract][Full Text] [Related]
4. Transcriptionally elevation of miR-494 by new ChlA-F compound via a HuR/JunB axis inhibits human bladder cancer cell invasion.
Tian Z; Luo Y; Zhu J; Hua X; Xu J; Huang C; Jin H; Huang H; Huang C
Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):822-833. PubMed ID: 31167152
[TBL] [Abstract][Full Text] [Related]
5. Isorhapontigenin (ISO) Inhibits Invasive Bladder Cancer Formation In Vivo and Human Bladder Cancer Invasion In Vitro by Targeting STAT1/FOXO1 Axis.
Jiang G; Wu AD; Huang C; Gu J; Zhang L; Huang H; Liao X; Li J; Zhang D; Zeng X; Jin H; Huang H; Huang C
Cancer Prev Res (Phila); 2016 Jul; 9(7):567-80. PubMed ID: 27080594
[TBL] [Abstract][Full Text] [Related]
6. Induction of RAC1 protein translation and MKK7/JNK-dependent autophagy through dicer/miR-145/SOX2/miR-365a axis contributes to isorhapontigenin (ISO) inhibition of human bladder cancer invasion.
Hua X; Xiang D; Guo M; Qian X; Chen R; Li T; Tian Z; Xu J; Huang C; Xie Q; Huang C
Cell Death Dis; 2022 Aug; 13(8):753. PubMed ID: 36045117
[TBL] [Abstract][Full Text] [Related]
7. Overexpressed miR-200a promotes bladder cancer invasion through direct regulating Dicer/miR-16/JNK2/MMP-2 axis.
Yang R; Xu J; Hua X; Tian Z; Xie Q; Li J; Jiang G; Cohen M; Sun H; Huang C
Oncogene; 2020 Feb; 39(9):1983-1996. PubMed ID: 31772330
[TBL] [Abstract][Full Text] [Related]
8. Loss of miR-638 in vitro promotes cell invasion and a mesenchymal-like transition by influencing SOX2 expression in colorectal carcinoma cells.
Ma K; Pan X; Fan P; He Y; Gu J; Wang W; Zhang T; Li Z; Luo X
Mol Cancer; 2014 May; 13():118. PubMed ID: 24885288
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional and post-transcriptional upregulation of p27 mediates growth inhibition of isorhapontigenin (ISO) on human bladder cancer cells.
Jiang G; Huang C; Li J; Huang H; Wang J; Li Y; Xie F; Jin H; Zhu J; Huang C
Carcinogenesis; 2018 Mar; 39(3):482-492. PubMed ID: 29409027
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-106b induced breast cancer cell invasion and motility in association with overexpression of matrix metalloproteinase 2.
Ni X; Xia T; Zhao Y; Zhou W; Wu N; Liu X; Ding Q; Zha X; Sha J; Wang S
Cancer Sci; 2014 Jan; 105(1):18-25. PubMed ID: 24164962
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑34a‑5p serves as a tumor suppressor by regulating the cell motility of bladder cancer cells through matrix metalloproteinase‑2 silencing.
Chou KY; Chang AC; Tsai TF; Lin YC; Chen HE; Ho CY; Chen PC; Hwang TI
Oncol Rep; 2021 Mar; 45(3):911-920. PubMed ID: 33650650
[TBL] [Abstract][Full Text] [Related]
12. Post-transcriptional regulation of MMP2 mRNA by its interaction with miR-20a and Nucleolin in breast cancer cell lines.
Das S; De S; Sengupta S
Mol Biol Rep; 2021 Mar; 48(3):2315-2324. PubMed ID: 33788053
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MBNL1-AS1 represses cell proliferation and enhances cell apoptosis via targeting miR-135a-5p/PHLPP2/FOXO1 axis in bladder cancer.
Wei X; Yang X; Wang B; Yang Y; Fang Z; Yi C; Shi L; Song D
Cancer Med; 2020 Jan; 9(2):724-736. PubMed ID: 31769229
[TBL] [Abstract][Full Text] [Related]
14. Isorhapontigenin (ISO) inhibits stem cell-like properties and invasion of bladder cancer cell by attenuating CD44 expression.
Luo Y; Tian Z; Hua X; Huang M; Xu J; Li J; Huang H; Cohen M; Huang C
Cell Mol Life Sci; 2020 Jan; 77(2):351-363. PubMed ID: 31222373
[TBL] [Abstract][Full Text] [Related]
15. TRIB3 supports breast cancer stemness by suppressing FOXO1 degradation and enhancing SOX2 transcription.
Yu JM; Sun W; Wang ZH; Liang X; Hua F; Li K; Lv XX; Zhang XW; Liu YY; Yu JJ; Liu SS; Shang S; Wang F; Yang ZN; Zhao CX; Hou XY; Li PP; Huang B; Cui B; Hu ZW
Nat Commun; 2019 Dec; 10(1):5720. PubMed ID: 31844113
[TBL] [Abstract][Full Text] [Related]
16. PHLPP2 stabilization by p27 mediates its inhibition of bladder cancer invasion by promoting autophagic degradation of MMP2 protein.
Peng M; Wang J; Zhang D; Jin H; Li J; Wu XR; Huang C
Oncogene; 2018 Oct; 37(43):5735-5748. PubMed ID: 29930380
[TBL] [Abstract][Full Text] [Related]
17. SOX2 promotes the migration and invasion of laryngeal cancer cells by induction of MMP-2 via the PI3K/Akt/mTOR pathway.
Yang N; Hui L; Wang Y; Yang H; Jiang X
Oncol Rep; 2014 Jun; 31(6):2651-9. PubMed ID: 24700142
[TBL] [Abstract][Full Text] [Related]
18. miR-5188 augments glioma growth, migration and invasion through an SP1-modulated FOXO1-PI3K/AKT-c-JUN-positive feedback circuit.
Yi R; Yang S; Lin X; Zhong L; Liao Y; Hu Z; Huang T; Long H; Lin J; Wu Z; Xie C; Ding S; Luo J; Luo Q; Song Y
J Cell Mol Med; 2020 Oct; 24(20):11800-11813. PubMed ID: 32902145
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2.
Wang J; Zeng H; Li H; Chen T; Wang L; Zhang K; Chen J; Wang R; Li Q; Wang S
Cell Physiol Biochem; 2017; 43(2):717-732. PubMed ID: 28946143
[TBL] [Abstract][Full Text] [Related]
20. MiR-1/GOLPH3/Foxo1 Signaling Pathway Regulates Proliferation of Bladder Cancer.
Liu MK; Ma T; Yu Y; Suo Y; Li K; Song SC; Zhang W
Technol Cancer Res Treat; 2019; 18():1533033819886897. PubMed ID: 31714185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
